Shuaijun Lu

527 total citations · 1 hit paper
19 papers, 376 citations indexed

About

Shuaijun Lu is a scholar working on Molecular Biology, Biomedical Engineering and Biochemistry. According to data from OpenAlex, Shuaijun Lu has authored 19 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Biomedical Engineering and 3 papers in Biochemistry. Recurrent topics in Shuaijun Lu's work include Nanoplatforms for cancer theranostics (8 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Shuaijun Lu is often cited by papers focused on Nanoplatforms for cancer theranostics (8 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Shuaijun Lu collaborates with scholars based in China, Australia and United States. Shuaijun Lu's co-authors include Canhua Huang, Bowen Li, Feng Gao, Kangjia Luo, Rui Chen, Lin Liu, Jing Tang, Jing Zuo, Lei Li and Hailong Tian and has published in prestigious journals such as Food Chemistry, Biochemical and Biophysical Research Communications and ACS Applied Materials & Interfaces.

In The Last Decade

Shuaijun Lu

17 papers receiving 371 citations

Hit Papers

Drug-induced oxidative stress in cancer treatments: Angel... 2023 2026 2024 2025 2023 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Drug-induced oxidative stress in cancer treatments: Angel or devil?
    2023 122 citations Jing Zuo, Bowen Li et al. Redox Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuaijun Lu China 10 185 105 60 50 50 19 376
Hyeoncheol Kim United States 6 209 1.1× 44 0.4× 80 1.3× 30 0.6× 34 0.7× 9 434
Mingdong Jiang China 14 233 1.3× 70 0.7× 72 1.2× 37 0.7× 50 1.0× 24 447
Shane R. Solst United States 6 151 0.8× 53 0.5× 68 1.1× 18 0.4× 79 1.6× 12 337
Katherine M. Weh United States 10 254 1.4× 66 0.6× 96 1.6× 27 0.5× 26 0.5× 22 470
Peiliang Shen China 13 228 1.2× 123 1.2× 33 0.6× 62 1.2× 30 0.6× 23 485
Xianbao Shi China 12 206 1.1× 48 0.5× 41 0.7× 21 0.4× 33 0.7× 49 407
Wenya Feng China 14 133 0.7× 66 0.6× 60 1.0× 18 0.4× 42 0.8× 26 391
Francisca E. Cara Spain 11 159 0.9× 66 0.6× 51 0.8× 20 0.4× 18 0.4× 15 387
Songtao Dong China 12 214 1.2× 61 0.6× 65 1.1× 87 1.7× 16 0.3× 19 478
Yanguo Su China 12 138 0.7× 84 0.8× 36 0.6× 48 1.0× 35 0.7× 18 363

Countries citing papers authored by Shuaijun Lu

Since Specialization
Citations

This map shows the geographic impact of Shuaijun Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuaijun Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuaijun Lu more than expected).

Fields of papers citing papers by Shuaijun Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuaijun Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuaijun Lu. The network helps show where Shuaijun Lu may publish in the future.

Co-authorship network of co-authors of Shuaijun Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Shuaijun Lu. A scholar is included among the top collaborators of Shuaijun Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuaijun Lu. Shuaijun Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
3.
Shen, Zhisen, Hao Jiang, Shuaijun Lu, et al.. (2025). Curcumin-based polymer prodrug nanoplatform for high-efficiency immunotherapy by synergistically suppression of head and neck cancer cell stemness. Journal of Nanobiotechnology. 23(1). 500–500.
4.
Li, Ziliang, Yufei Liu, Shuaijun Lu, et al.. (2025). pH-driven plant protein nanoparticles modulated by flaxseed gum oligosaccharides for apigenin delivery. Food Chemistry. 496(Pt 3). 146835–146835.
5.
Lu, Shuaijun, et al.. (2024). Histone methyltransferase WHSC1 cooperate with YBX1 promote glioblastoma progression via regulating PLK1 expression. Cellular Signalling. 124. 111471–111471. 1 indexed citations
6.
Li, Min, Gang Guo, Shuaijun Lu, et al.. (2024). Perilla Seed Oil: A Review of Health Effects, Encapsulation Strategies and Applications in Food. Foods. 13(22). 3615–3615. 4 indexed citations
7.
Tian, Hailong, Zhihan Wang, Bowen Li, et al.. (2023). Laser-activatable oxygen self-supplying nanoplatform for efficiently overcoming colorectal cancer resistance by enhanced ferroptosis and alleviated hypoxic microenvironment. Biomaterials Research. 27(1). 92–92. 6 indexed citations
8.
9.
Zuo, Jing, Bowen Li, Rui Chen, et al.. (2023). Drug-induced oxidative stress in cancer treatments: Angel or devil?. Redox Biology. 63. 102754–102754. 122 indexed citations breakdown →
10.
Tian, Hailong, Chan Li, Lei Li, et al.. (2023). Photothermal‐Starvation Therapy Nanomodulator Capable of Inhibiting Colorectal Cancer Recurrence and Metastasis by Energy Metabolism Reduction. Advanced Healthcare Materials. 12(26). e2300968–e2300968. 11 indexed citations
11.
Ding, Ning, Hailong Tian, Lei Li, et al.. (2023). Carrier-free delivery of thymopentin-regulated injectable nanogels via an enhanced cancer immunity cycle against melanoma metastasis. Materials Today Bio. 20. 100645–100645. 12 indexed citations
12.
Wang, Fang, et al.. (2022). PUF60 promotes glioblastoma progression through regulation of EGFR stability. Biochemical and Biophysical Research Communications. 636(Pt 1). 190–196. 6 indexed citations
13.
Lu, Shuaijun, Hailong Tian, Lei Li, et al.. (2022). Nanoengineering a Zeolitic Imidazolate Framework‐8 Capable of Manipulating Energy Metabolism against Cancer Chemo‐Phototherapy Resistance. Small. 18(48). e2204926–e2204926. 34 indexed citations
14.
Li, Lei, Hailong Tian, Zhe Zhang, et al.. (2022). Carrier-Free Nanoplatform via Evoking Pyroptosis and Immune Response against Breast Cancer. ACS Applied Materials & Interfaces. 15(1). 452–468. 53 indexed citations
15.
Lu, Shuaijun, et al.. (2022). Managing Cancer Drug Resistance from the Perspective of Inflammation. Journal of Oncology. 2022. 1–13. 20 indexed citations
16.
Wang, Weihua, Shuaijun Lu, Feng Wang, et al.. (2018). Curcumin inhibits proliferation and enhances apoptosis in A549 cells by downregulating lncRNA UCA1.. PubMed. 73(7). 402–407. 40 indexed citations
17.
Li, Qian, et al.. (2016). Association between the maternal serum levels of 19 eicosanoids and pre‐eclampsia. International Journal of Gynecology & Obstetrics. 133(3). 291–296. 17 indexed citations
18.
Zhong, Guoliang, Qian Li, Na Lin, et al.. (2015). Detection of 19 types of para-arachidonic acids in five types of plasma/serum by ultra performance liquid chromatography-tandem mass spectrometry.. PubMed. 8(6). 9248–56. 2 indexed citations
19.
Lu, Shuaijun, et al.. (2014). Effect of 20-hydroxyeicosatetraenoic acid on biological behavior of human villous trophoblasts and uterine vascular smooth muscle cells. Molecular Medicine Reports. 9(5). 1889–1894. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hyeoncheol Kim Breakdown of academic impact, for papers by Mingdong Jiang Breakdown of academic impact, for papers by Shane R. Solst Breakdown of academic impact, for papers by Katherine M. Weh Breakdown of academic impact, for papers by Peiliang Shen Breakdown of academic impact, for papers by Xianbao Shi Breakdown of academic impact, for papers by Wenya Feng Breakdown of academic impact, for papers by Francisca E. Cara Breakdown of academic impact, for papers by Songtao Dong Breakdown of academic impact, for papers by Yanguo Su
Rankless by CCL
2026